Login / Signup

Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment-Related Complication Hospitalizations in the United States.

Gabriel S TajeuNatalia Ruiz-NegrónAndrew E MoranZugui ZhangPaul KolmWilliam S WeintraubAdam P BressBrandon K Bellows
Published in: Circulation. Cardiovascular quality and outcomes (2024)
The hospitalization cost estimates and statistical code reported in the current study have the potential to increase transparency and comparability of cost-effectiveness analyses for CVD in the United States.
Keyphrases
  • cardiovascular disease
  • type diabetes
  • cardiovascular risk factors
  • risk assessment
  • metabolic syndrome
  • combination therapy
  • replacement therapy